CN101028421B - Chinese medicine for treating chronic kidney failure - Google Patents
Chinese medicine for treating chronic kidney failure Download PDFInfo
- Publication number
- CN101028421B CN101028421B CN200710065490A CN200710065490A CN101028421B CN 101028421 B CN101028421 B CN 101028421B CN 200710065490 A CN200710065490 A CN 200710065490A CN 200710065490 A CN200710065490 A CN 200710065490A CN 101028421 B CN101028421 B CN 101028421B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- chronic kidney
- radix
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating chronic renal failure is prepared from more than 10 Chinese- medicinal materials including astragalus root, notoginseng, epimedium, ground beetle, etc.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine for the treatment of chronic kidney hypofunction, is that a kind of chronic kidney hypofunction for the treatment of is the Chinese patent medicine of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
Chronic renal failure (chronic kidney hypofunction) is because the result of kidney damage that a variety of causes causes and the deterioration of carrying out property, body is at the excretion metabolism product, regulate water, electrolyte, acid-base balance, and the clinical syndrome that gets muddled of aspects such as the generation of some endocrine activity material and deactivation.Common clinically asthenia, feel sick, symptom such as vomiting, anemia, oliguria, edema and impaired renal function, Water-Electrolyte disorder etc.Chronic kidney hypofunction belongs to categories such as " difficulty in urination ", " obstruction and rejection ", " edema ", " asthenia " in the traditional Chinese medical science.
Chronic kidney hypofunction can be by multiple kidney disease development such as edema, stranguria, hematuria.The traditional Chinese medical science thinks that with the passing of time various nephropathy, undermine each function, and based on the spleen damage of suffering from a deficiency of the kidney, the state of an illness progressively develops and aggravates disease, and causes the positive deficiency of vital energy to decline at last, and turbid pathogen, blood stasis are stopped up the kidney network that stagnates, cause kidney to lose out entire function, the retention of turbid damp uremic is in body, and the initiation primary disease.In its evolution, often, some factor accelerates owing to making course of disease progress, and sb.'s illness took a turn for the worse.Common inducement such as being invaded by exogenous pathogen, eating and drinking without temperance, overstrain etc.The traditional Chinese medical science is divided into clinically: the dialectical treatments of disease type such as spleen deficiency of kidney-QI, deficiency of spleen-YANG and kidneyYANG, the hepatic and renal YIN deficiency, deficiency of both YIN and YANG, and the progress of delaying chronic kidney hypofunction, evident in efficacy.
The method of western medical treatment primary disease is a lot, comprises hemodialysis, peritoneal dialysis and renal transplantation etc., brings very heavy mental burden and financial burden for patient and household, and side effect is in various degree arranged.
Summary of the invention
The present invention develops in conjunction with the latest modern technological scientific achievement on the basis of traditional tcm syndrome differentiation and treatment.The purpose of this invention is to provide a kind of Chinese patent medicine for the treatment of chronic kidney hypofunction, and have determined curative effect, safe ready, little, the cheap characteristics of side effect.
The present invention is made by the following weight proportion raw material:
1.5～6 parts of 0.1～0.5 portion of Polyporus of 3～12 parts of Radix Notoginseng powder of Radix Astragali
1.0～4 parts of 0.1～2 portion of Rhizoma Alismatis of 1.5～6 parts of Eupolyphaga Seu Steleophagas of Herba Epimedii
1.0～4 parts of 0.1～2 portion of Rhizoma Dioscoreaes of 1.0～4 parts of Flos Sophorae of Radix Rehmanniae
0.1～2 part of 0.1～2 part of Ramulus Cinnamomi of 1.5～6 portions of Semen Plantaginiss of Rhizoma Smilacis Glabrae
The weight proportion of each raw material of optimization formula of the present invention is:
2.5～3.5 parts of 0.2～0.4 portion of Polyporus of 4～8 parts of Radix Notoginseng powder of Radix Astragali
1.5～2.5 parts of 0.5～1.5 portion of Rhizoma Alismatis of 2.5～3.5 parts of Eupolyphaga Seu Steleophagas of Herba Epimedii
1.5～2.5 parts of 0.5～1.5 portion of Rhizoma Dioscoreaes of 1.5～2.5 parts of Flos Sophorae of Radix Rehmanniae
0.5～1.5 part of 0.5～1.5 part of Ramulus Cinnamomi of 2.5～3.5 portions of Semen Plantaginiss of Rhizoma Smilacis Glabrae
The weight proportion of each raw material of optimum formula of the present invention is:
3 parts of 0.3 portion of Polyporus of 6 parts of Radix Notoginseng powder of Radix Astragali
2 parts of 1 portion of Rhizoma Alismatis of 3 parts of Eupolyphaga Seu Steleophagas of Herba Epimedii
2 parts of 1 portion of Rhizoma Dioscoreaes of 2 parts of Flos Sophorae of Radix Rehmanniae
1 part of 1 part of Ramulus Cinnamomi of 3 portions of Semen Plantaginiss of Rhizoma Smilacis Glabrae
Drug action mechanism among the present invention is as follows:
The Radix Astragali nature and flavor are sweet, warm.Return lung, spleen channel.Have benefit and defend consolidating superficial resistance, inducing diuresis to remove edema, poison holding, the effect of granulation promoting.That can treat that internal injury overstrain, diarrhea due to hypofunction of the spleen, proctoptosis, deficiency of vital energy blood prostration, metrorrhagia and leukorrhagia, spontaneous perspiration, night sweat, arthralgia due to stagnation of blood, edema, carbuncle do not burst or burst does not hold back and the disease of all weakness of QI blood deficiency etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1074th page).
Sweet, the little hardship of Radix Notoginseng powder nature and flavor, temperature.Return liver, stomach, large intestine channel.Has the dissipating blood stasis hemostasis, the effect of subduing swelling and relieving pain.Can treat haematemesis, hemoptysis, epistaxis, have blood in stool, dysentery, metrorrhagia, lump in the abdomen, puerperal blood faints, retention of lochia, traumatic hemorrhage, breast ventral spine pain, fall and pounce on blood stasis, carbuncle pain, acute pharyngolaryngitis, Light-headedness, tinnitus, coronary heart disease, angina pectoris, acute necrosis sections enteritis, venom, bee sting, rheumatic arthritis disease, hypertension etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 60th page).
The Polyporus nature and flavor are sweet, light, flat.Return spleen, kidney, urinary bladder channel.Have diuresis eliminating dampness by diuresis, anticancer effect.Can treat dysuria, edema distension, beriberi, urinary system infection, diarrhoea, stranguria with turbid discharge, leukorrhagia etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1122nd page).
Herba Epimedii nature and flavor suffering, sweet, warm.Return liver, kidney channel.Effect with kidney invigorating and YANG supporting, expelling wind and removing dampness, bone and muscle strengthening.Can treat that sexual impotence erectile problem, dribbling urination, muscles and bones contraction urgency, hemiplegia, weakness of the waist and knees, rheumatic arthralgia, extremity are meciless, climacteric hypertension disease, Mental fatigue are forgetful, neurasthenia, osteomyelitis etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1143rd page).
The Eupolyphaga Seu Steleophaga nature and flavor are salty, cold, slightly poisonous.Return Liver Channel.Has promoting blood circulation to remove blood stasis, inducing menstruation to relieve menalgia, the abdominal mass that disappears, the effect of reunion of bone.Ke Zhi Liao lumps in the chest and abdomen, amenorrhea due to stagnation of blood, postnatal blood stasis stomachache, traumatic injury, swollen and rigid tongue, congenital deformity of the tongue, the muscles and bones folding is hindered hepatosplenomegaly, an emaciation due to blood disorder, scarlet fever, erysipelas etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 91st page).
The Rhizoma Alismatis nature and flavor are sweet, cold.Return kidney, urinary bladder channel.Has diuresis, the effect of clearing away damp-heat.Can treat dysuria, edema distension, the oliguria of having loose bowels, dizziness due to fluid-retention, the puckery pain of pyretic stranguria; Hyperlipidemia etc.(the 184th page of Chemical Industry Press of Pharmacopoeia of the People's Republic of China version in 2000 is compiled by Chinese Pharmacopoeia Commission).
The Radix Rehmanniae nature and flavor are sweet, cold.GUIXIN, liver, kidney channel.Has clearing away heat and cooling blood, yin nourishing, the effect of promoting the production of body fluid.Can treat that calentura crimson tongue excessive thirst, interior-heat caused by deficiency of YIN, hectic fever due to YIN-deficiency consumptive fever, interior-heat are quenched one's thirst, haematemesis, epistaxis, send out speckle dermexanthesis etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 514th page).
Flos Sophorae nature and flavor hardship is slightly cold.Return liver, large intestine channel.Has cooling blood for hemostasis, the effect of liver heat removing and eyesight improving.Cure mainly discharging fresh blood stool, the hemorrhoid hematochezia, dysentery with red and white feces, stranguria with blood, epistaxis, sore swollen toxin etc. are spitted blood in metrorrhagia.(the 3440th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
The Rhizoma Dioscoreae nature and flavor are sweet, flat.Return spleen, lung, kidney channel.Have spleen reinforcing, support lung, reinforce the kidney, the effect that benefit is smart.Cure mainly diarrhea due to hypofunction of the spleen, the lack of appetite edema, cough and asthma due to lung deficiency is quenched one's thirst, seminal emission, leukorrhagia.The frequent micturition etc. of suffering from a deficiency of the kidney.(the 218th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
The Rhizoma Smilacis Glabrae nature and flavor are sweet, light, flat.Return liver, stomach warp.Has heat-clearing and toxic substances removing, wind-damp dispelling, bone and muscle strengthening, sharp joint, anticancer effect.Can treat damp and hot sore, eczema, rheumatic ostalgia, the limbs contracture, the Fructus Myricae rubrae malignant boil, urinary system infection, syphilis, stranguria with turbid discharge, the stranguria leucorrhea, dyspepsia, diarrhoea, beriberi is treated skin ulcer, carbuncle, scrofula etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 87th page).
The Semen Plantaginis nature and flavor are sweet, be slightly cold.Return liver, kidney, lung, small intestinal, urinary bladder channel.Has clearing away heat and promoting diuresis, eliminating dampness by diuresis antidiarrheal, liver heat removing and eyesight improving, the effect of removing heat from the lung and dissipating phlegm.Can treat the cough due to lung-heat, urinary system infection, calculus, gastritis, dysuria, enteritis, bacillary dysentery, acute icterohepatitisshock, bronchitis, acute eye conjunctivitis, stranguria with turbid discharge, leukorrhagia, hematuria, edema, hematodiarrhoea is had loose bowels, epistaxis, conjunctival congestion and swelling pain, sore throat tonsillitis, cough, skin ulcer etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 291st page).
Ramulus Cinnamomi nature and flavor suffering, sweet, warm.GUIXIN, bladder, lung meridian.Has the diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, the cold-damp of dispeling the wind, the horizontal logical podomere of row upper limb, activating YANG and prormoting functioning of QI, the effect of the flat gas that spins.Can treat exterior syndrome due to wind-cold, shoulder back of the body podomere is ached, thoracic obstruction phlegm retention, amenorrhea lump in the abdomen, rheumatic arthralgia, cold, cough with asthma phlegm retention, amenorrhea stomachache etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 980th page).
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", is monarch drug with Radix Astragali, Radix Notoginseng powder, Polyporus, Herba Epimedii and Eupolyphaga Seu Steleophaga, is ministerial drug with Rhizoma Alismatis, Radix Rehmanniae, Rhizoma Dioscoreae, Flos Sophorae and Rhizoma Smilacis Glabrae, is adjuvant with Semen Plantaginis and Ramulus Cinnamomi.All medicine phases and tool vital energy benefiting and the kidney invigorating altogether, the effect of inducing diuresis to remove edema, the treatment chronic kidney hypofunction has determined curative effect, has no side effect taking convenience, cheap characteristics.
Chinese patent medicine of the present invention, can add the medicine acceptable carrier when being prepared into medicament, described medicine acceptable carrier can be: starch, sucrose, lactose, mannitol, silicon derivative, cellulose family and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, soil temperature 80, agar, calcium carbonate, calcium bicarbonate, surfactant, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, phospholipid material, Kaolin, Pulvis Talci, calcium stearate, magnesium stearate etc.
Chinese patent medicine of the present invention can be any pharmaceutically useful dosage form, and these dosage forms comprise: tablet, sugar coated tablet, film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, oral liquid, buccal tablet, granule, pill, powder, unguentum, sublimed preparation, suspensoid, powder, solution, injection, suppository, ointment, plaster, cream, spray, drop, patch.Preparation of the present invention, preferred Chinese patent medicine is a peroral dosage form, as: tablet, capsule, oral liquid, buccal tablet, granule, pill, powder, suspensoid, powder, solution, drop, drop pill.Preferred Chinese patent medicine is capsule, tablet, granule.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment chronic kidney hypofunction of the Chinese medicine of respectively distinguishing the flavor of, and is nontoxic to human body.Show that through animal acute toxicity experiment the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, rich in proteins in the medicine, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid, also contain various trace elements such as Saponin, plant sterol and calcium, be beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention not only can effectively treat chronic kidney hypofunction, and the prevention of chronic kidney hypofunction is also had good effect, has improved patient's life quality greatly, and higher healing rehabilitation efficacy is arranged.
Chronic kidney hypofunction (difficulty in urination) diagnosis basis: (the 219th page of chief editor's " traditional Chinese medical science disease diagnosis and treatment standard and prescription are selected for use " People's Health Publisher's calendar year 2001 version such as Dai Shen).
1, dysuria, drop are not smooth, or urine is inaccessible obstructed, and urethra does not have puckery pain, little distention and fullness in the abdomen.
2, be more common in elderly men, or postpartum women and operation back patient.
3, prostate hyperplasia is checked in male's rectal touch, or the obvious voiced sound of bladder area percussion.
4, do inspections such as cystoscope, B ultrasonic, abdominal X-ray, help diagnosis.
Chronic kidney hypofunction (difficulty in urination) efficacy assessment standard: (the 222nd page of chief editor's " traditional Chinese medical science disease diagnosis and treatment standard and prescription are selected for use " People's Health Publisher's calendar year 2001 version such as Dai Shen).
1, cure: it is unobstructed to urinate, and symptom and sign disappear.
2, take a turn for the better: symptom and sign are improved.
3, do not heal: the symptom no change.
Further specify the therapeutic effect of medicine of the present invention below by the clinical practice example to the treatment chronic kidney hypofunction
As follows through clinical test results; Treatment chronic kidney hypofunction patient 97 examples.Take embodiment 1 capsule, each 2-10 grain, every day three to four times, eliminating cold for resuscitation water send down, and take half an hour ante cibum.Two months is a course of treatment, take continuously three the course of treatment observe the curative effect.Cure 51 examples and account for 52.58%, 35 examples that take a turn for the better account for 36.08%, and more 11 examples do not account for 11.34%, and total effective rate reaches 88.66%.After three course of therapy, patient's asthenia, feel sick, symptoms such as vomiting, anemia, oliguria, edema all have clear improvement.And patient does not have any untoward reaction, and three big routine tests and hepatic and renal function detect no abnormal.
The specific embodiment
Embodiment 1 capsule takes by weighing raw material by following weight:
3 parts of 0.3 portion of Polyporus of 6 parts of Radix Notoginseng powder of Radix Astragali
2 parts of 1 portion of Rhizoma Alismatis of 3 parts of Eupolyphaga Seu Steleophagas of Herba Epimedii
2 parts of 1 portion of Rhizoma Dioscoreaes of 2 parts of Flos Sophorae of Radix Rehmanniae
1 part of 1 part of Ramulus Cinnamomi of 3 portions of Semen Plantaginiss of Rhizoma Smilacis Glabrae
Preparation method is to get Radix Notoginseng powder drying and crushing to 120～200 order fine powders earlier, get Radix Astragali again, Polyporus, Herba Epimedii, Eupolyphaga Seu Steleophaga, Rhizoma Alismatis, Radix Rehmanniae, Flos Sophorae, Rhizoma Dioscoreae, Rhizoma Smilacis Glabrae, Semen Plantaginis and Ramulus Cinnamomi decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, and reclaimed ethanol, when 50 degree～55 are spent, be concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and Radix Notoginseng powder fine powder mixing, drying is ground into fine powder, incapsulates.Adorn 0.3 gram for every, usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, one month is a course of treatment.
Embodiment 2 tablets take by weighing raw material by following weight:
3 parts of 0.3 portion of Polyporus of 6 parts of Radix Notoginseng powder of Radix Astragali
2 parts of 1 portion of Rhizoma Alismatis of 3 parts of Eupolyphaga Seu Steleophagas of Herba Epimedii
2 parts of 1 portion of Rhizoma Dioscoreaes of 2 parts of Flos Sophorae of Radix Rehmanniae
1 part of 1 part of Ramulus Cinnamomi of 3 portions of Semen Plantaginiss of Rhizoma Smilacis Glabrae
Preparation method is to get Radix Notoginseng powder drying and crushing to 120～200 order fine powders earlier, get Radix Astragali again, Polyporus, Herba Epimedii, Eupolyphaga Seu Steleophaga, Rhizoma Alismatis, Radix Rehmanniae, Flos Sophorae, Rhizoma Dioscoreae, Rhizoma Smilacis Glabrae, Semen Plantaginis and Ramulus Cinnamomi decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10 adds ethanol and makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and Radix Notoginseng powder fine powder mixing, drying, be ground into fine powder, add an amount of magnesium stearate, tabletting, sugar coating are promptly.Usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, one month is a course of treatment.
Embodiment 3 granules take by weighing raw material by following weight:
3 parts of 0.3 portion of Polyporus of 6 parts of Radix Notoginseng powder of Radix Astragali
2 parts of 1 portion of Rhizoma Alismatis of 3 parts of Eupolyphaga Seu Steleophagas of Herba Epimedii
2 parts of 1 portion of Rhizoma Dioscoreaes of 2 parts of Flos Sophorae of Radix Rehmanniae
1 part of 1 part of Ramulus Cinnamomi of 3 portions of Semen Plantaginiss of Rhizoma Smilacis Glabrae
Preparation method is to get Radix Notoginseng powder drying and crushing to 120～200 order fine powders earlier, get Radix Astragali again, Polyporus, Herba Epimedii, Eupolyphaga Seu Steleophaga, Rhizoma Alismatis, Radix Rehmanniae, Flos Sophorae, Rhizoma Dioscoreae, Rhizoma Smilacis Glabrae, Semen Plantaginis and Ramulus Cinnamomi decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10 adds ethanol and makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and Radix Notoginseng powder fine powder mixing, drying, be ground into fine powder, add an amount of sucrose and soluble starch, alcohol granulation, the pack of dry back is promptly.Usually half an hour ante cibum warm boiled water, one time 1～3 bag, three to four times on the one, one month is a course of treatment.
Claims (3)
1. Chinese patent medicine for the treatment of chronic kidney hypofunction is characterized in that it is made by following raw materials by weight proportions:
1.5～6 parts of 0.1～0.5 portion of Polyporus of 3～12 parts of Radix Notoginseng powder of Radix Astragali
1.0～4 parts of 0.1～2 portion of Rhizoma Alismatis of 1.5～6 parts of Eupolyphaga Seu Steleophagas of Herba Epimedii
1.0～4 parts of 0.1～2 portion of Rhizoma Dioscoreaes of 1.0～4 parts of Flos Sophorae of Radix Rehmanniae
0.1～2 part of 0.1～2 part of Ramulus Cinnamomi of 1.5～6 portions of Semen Plantaginiss of Rhizoma Smilacis Glabrae.
2. a kind of Chinese patent medicine for the treatment of chronic kidney hypofunction according to claim 1, wherein the weight proportion of each crude drug is:
2.5～3.5 parts of 0.2～0.4 portion of Polyporus of 4～8 parts of Radix Notoginseng powder of Radix Astragali
1.5～2.5 parts of 0.5～1.5 portion of Rhizoma Alismatis of 2.5～3.5 parts of Eupolyphaga Seu Steleophagas of Herba Epimedii
1.5～2.5 parts of 0.5～1.5 portion of Rhizoma Dioscoreaes of 1.5～2.5 parts of Flos Sophorae of Radix Rehmanniae
0.5～1.5 part of 0.5～1.5 part of Ramulus Cinnamomi of 2.5～3.5 portions of Semen Plantaginiss of Rhizoma Smilacis Glabrae.
3. a kind of Chinese patent medicine for the treatment of chronic kidney hypofunction according to claim 1, wherein the weight proportion of each crude drug is:
3 parts of 0.3 portion of Polyporus of 6 parts of Radix Notoginseng powder of Radix Astragali
2 parts of 1 portion of Rhizoma Alismatis of 3 parts of Eupolyphaga Seu Steleophagas of Herba Epimedii
2 parts of 1 portion of Rhizoma Dioscoreaes of 2 parts of Flos Sophorae of Radix Rehmanniae
1 part of 1 part of Ramulus Cinnamomi of 3 portions of Semen Plantaginiss of Rhizoma Smilacis Glabrae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710065490A CN101028421B (en) | 2007-04-16 | 2007-04-16 | Chinese medicine for treating chronic kidney failure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710065490A CN101028421B (en) | 2007-04-16 | 2007-04-16 | Chinese medicine for treating chronic kidney failure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101028421A CN101028421A (en) | 2007-09-05 |
| CN101028421B true CN101028421B (en) | 2010-05-19 |
Family
ID=38714078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710065490A Expired - Fee Related CN101028421B (en) | 2007-04-16 | 2007-04-16 | Chinese medicine for treating chronic kidney failure |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101028421B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843695B (en) * | 2009-09-25 | 2011-07-27 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic kidney failure |
| CN101785776B (en) * | 2010-04-02 | 2011-07-27 | 西北大学 | Application of ergot sterone in preparation of medicaments for treating chronic renal failure |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1268355A (en) * | 2000-01-08 | 2000-10-04 | 陈柏林 | Yichanmanshenkang medicine for curing nephroses |
| CN1544029A (en) * | 2003-11-11 | 2004-11-10 | 袁发焕 | Medicine for treating chronic kidney failure and its preparing process |
-
2007
- 2007-04-16 CN CN200710065490A patent/CN101028421B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1268355A (en) * | 2000-01-08 | 2000-10-04 | 陈柏林 | Yichanmanshenkang medicine for curing nephroses |
| CN1544029A (en) * | 2003-11-11 | 2004-11-10 | 袁发焕 | Medicine for treating chronic kidney failure and its preparing process |
Non-Patent Citations (4)
| Title |
|---|
| 吕勇.中医药治疗系膜增生性肾小球肾炎的研究进展.安徽中医学院学报25 2.2006,25(2),第70页第1栏第1段-第72页第1栏最后1段. |
| 吕勇.中医药治疗系膜增生性肾小球肾炎的研究进展.安徽中医学院学报25 2.2006,25(2),第70页第1栏第1段-第72页第1栏最后1段. * |
| 邓远卉,印国银.中西医结合治疗慢性肾功能衰竭研究进展.现代中西医结合杂志13 8.2004,13(8),第1109页第1栏第1段-第2栏最后1段. |
| 邓远卉,印国银.中西医结合治疗慢性肾功能衰竭研究进展.现代中西医结合杂志13 8.2004,13(8),第1109页第1栏第1段-第2栏最后1段. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101028421A (en) | 2007-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101019984B (en) | Constipation treating Chinese medicine preparation | |
| CN101019985B (en) | Constipation treating Chinese medicine | |
| CN101129994A (en) | Traditional Chinese medicine composition for treating icterus | |
| CN100415265C (en) | A Chinese traditional medicinal preparation for treatment of eczema | |
| CN102366541B (en) | Traditional Chinese medicine composition for treatment of diabetes | |
| CN101028506B (en) | Chinese-medicinal decoction for treating difficult menstruation | |
| CN104027462B (en) | A kind of Chinese medicine preparation for the treatment of osteoarthritis and preparation method thereof | |
| CN101085314A (en) | Chinese patent medicine for treating delayed menstruation | |
| CN100431578C (en) | Preparation of Chinese traditional medicine for treating hyperplasia of prostate | |
| CN101028421B (en) | Chinese medicine for treating chronic kidney failure | |
| CN100431592C (en) | Chinese medicinal formulation for treating hyperplasia of prostate | |
| CN101028492B (en) | Chinese preparation for treating hysteromyoma | |
| CN100381141C (en) | Chinese medicine for treating prostatic hyperplasia | |
| CN100415288C (en) | A Chinese traditional medicinal preparation for treatment of psoriasis | |
| CN104225490A (en) | Traditional Chinese medicine for treating cholecystitis | |
| CN100571725C (en) | A kind of Chinese medicine preparation for the treatment of sciatica | |
| CN100450537C (en) | Chinese medicinal formulation for treating prostate hyperplasia | |
| CN101129679A (en) | Chinese medicine composition for treating constipation | |
| CN101085249A (en) | Traditional Chinese medicine for treating preceded menstrual cycle | |
| CN101129483A (en) | Traditional Chinese medicine formulated product for treating pantalgia after childbirth | |
| CN104383403A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN101085338A (en) | Traditional Chinese medicine preparation for curing uric acid nephritis | |
| CN101020032A (en) | Chinese medicine prepn for treating ischemic femoral head necrosis | |
| CN101019988B (en) | Diabetes treating Chinese medicine | |
| CN100382831C (en) | Eczema treating Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SINO-AMERICA INNOVATION UNITED INTERNATION Free format text: FORMER OWNER: BEIJING YIXINTANG MEDICINE INST. Effective date: 20110719 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 102300 NO. 2, YARD 191, DONGYANGTUO VILLAGE, JUNZHUANG TOWN, MENTOUGOU DISTRICT, BEIJING TO: 100076 NO. 10, EAST ALLEY 6, NORTH AREA, MINSHENG ROAD, VILLAGE 4, XIHONGMEN TOWN, DAXING DISTRICT, BEIJING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20110719 Address after: 100076, No. six, No. 10, North East Road, Minsheng Road, fourth village, Xihongmen Town, Beijing, Daxing District Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: Yang Tuo Cun 102300 Beijing city Mentougou District Jun Zhuang Zhen Dong Hospital No. 191 No. 2 Patentee before: Beijing Yixintang Medicine Inst. |
|
| ASS | Succession or assignment of patent right |
Owner name: CHEN YUTANG Free format text: FORMER OWNER: BEIJING SINO-US INNOVATION INSTITUTE OF INTERNATIONAL STUBBORN DISEASES Effective date: 20120316 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Yutang Inventor before: Wang Xinsuo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG XINSUO TO: CHEN YUTANG |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120316 Address after: 100076, Beijing Town, Daxing District Town, Xihongmen, four village, Minsheng Road, North East six, No. 10 Patentee after: Chen Yutang Address before: 100076, No. six, No. 10, North East Road, Minsheng Road, fourth village, Xihongmen Town, Beijing, Daxing District Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SINO-US INNOVATION UNITED INTERNATIONAL IN Free format text: FORMER OWNER: CHEN YUTANG Effective date: 20120419 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20120419 Address after: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: 100076, Beijing Town, Daxing District Town, Xihongmen, four village, Minsheng Road, North East six, No. 10 Patentee before: Chen Yutang |
|
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATION Effective date: 20121017 Owner name: BEIJING CHINESE AND FOREIGN XINCHUANG INTERNATIONA Free format text: FORMER OWNER: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATIONAL DIFFICULT DISEASE RESEARCH INSTITUTE Effective date: 20121017 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100076 DAXING, BEIJING TO: 100012 CHAOYANG, BEIJING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20121017 Address after: 100012 Beijing city Chaoyang District Shangli Road No. 201 Beijing Chinese New International Medical Research Institute Patentee after: Beijing new China International Pharmaceutical Research Institute Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATIONAL DIFFICULT DISEASE RESEARCH INSTITUTE Effective date: 20121121 Owner name: BEIJING JINKUI CHINESE MEDICAL RESEARCH INSTITUTE Free format text: FORMER OWNER: BEIJING CHINESE AND FOREIGN XINCHUANG INTERNATIONAL MEDICAL RESEARCH INSTITUTE Effective date: 20121121 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Lin Wanshuo Inventor before: Chen Yutang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN YUTANG TO: LIN WANSHUO Free format text: CORRECT: ADDRESS; FROM: 100012 CHAOYANG, BEIJING TO: 100010 DONGCHENG, BEIJING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20121121 Address after: 100010, No. 3-1, building 3, Beijing Hutong, Dongcheng District, China Patentee after: Beijing Jingui Chinese Medicine Research Institute Co. Ltd. Address before: 100012 Beijing city Chaoyang District Shangli Road No. 201 Beijing Chinese New International Medical Research Institute Patentee before: Beijing new China International Pharmaceutical Research Institute Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100519 Termination date: 20200416 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |